NOVEL ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION
$297,245N43FY2020AINIH
Casterbridge Pharmaceuticals, Inc., Winchester MA
Investigators
Abstract
To support the development of novel HBV therapeutics.
View original record on NIH RePORTER →